Coupling inflammation with evo-devo

Medical Hypotheses

Volumn 78, Issue 6, 2012, Pages 721-731

  Aller, María Angeles ^a   Arias, Natalia ^b   Fuentes Julian, Sherezade ^c   Blazquez Martinez, Alejandro ^c   Argudo, Salvador ^d   Miguel, Maria Paz de ^c   Arias, Jorge Luis ^b   Arias, Jaime ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^d Arganda del Rey   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN B; C REACTIVE PROTEIN; GLYCOSAMINOGLYCAN; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 6; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; PENTRAXIN; VERY LOW DENSITY LIPOPROTEIN; VITELLIN;

ADIPOSE TISSUE; ANOXIA; ANTIOXIDANT ACTIVITY; ARTICLE; CARDIOVASCULAR SYSTEM; CELL SWELLING; ELECTRON TRANSPORT; EMBRYO DEVELOPMENT; ENERGY EXPENDITURE; ENVIRONMENTAL CHANGE; ENVIRONMENTAL FACTOR; EVOLUTION; FATTY LIVER; GASTRULATION; GENETIC POLYMORPHISM; HUMAN; HYDRATION; HYDROLYSIS; INFLAMMATION; INNATE IMMUNITY; INSULIN RESISTANCE; ISCHEMIA; LIFESTYLE MODIFICATION; MAST CELL; METAMORPHOSIS; NONALCOHOLIC FATTY LIVER; ONTOGENY; OOCYTE; PATHOGENESIS; PATHOPHYSIOLOGY; PHYLOGENY; PROTEIN METABOLISM; VITELLOGENESIS;

ADAPTATION, BIOLOGICAL; ANIMALS; BIOLOGICAL EVOLUTION; ENVIRONMENT; GROWTH AND DEVELOPMENT; HUMANS; INFLAMMATION; MODELS, BIOLOGICAL; PHYLOGENY; WESTERN WORLD; WOUND HEALING;

ANIMALIA; INVERTEBRATA; VERTEBRATA;

EID: 84860382063     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.02.018     Document Type: Article

References (127)

1. Medzhitov R. Origin and physiological roles of inflammation. Nature 2008, 454:428-435.
2. Smale S.T. Selective transcription in response to an inflammatory stimulus. Cell 2010, 140:833-844.
3. Franceschi C., Bonafe M., Valensin S., et al. Inflamm-aging. An evolutionary perspective on immunosenescence. Ann N Y Acad Sci 2000, 908:244-254.
4. Franceschi C., Capri M., Monti D., et al. Inflammaging and anti-inflamming: a systemic perspective on aging and longevity emerged from studies in humans. Mech Ageing Dev 2007, 128:92-105.
5. Goto M. Inflammaging (inflammation+aging): a driving force for human aging based on an evolutionarily antagonistic pleiotropy theory?. Biosci Trends 2008, 2:218-230.
6. Caruso C., Lio D., Cavallone L., Franceschi C. Aging, longevity, inflammation and cancer. Ann N Y Acad Sci 2004, 1028:1-13.
7. Bürkle A., Caselli G., Franceschi C., et al. Pathophysiology of ageing, longevity and age related diseases. Immunol Aging 2007, 4:4.
8. Aller M.A., Arias J.L., Nava M.P., Arias J. Post-traumatic inflammation is a complex response based on the pathological expression of the nervous, immune, and endocrine functional systems. Exp Biol Med (Maywood) 2004, 229:170-181.
9. Nathan C., Ding A. Non resolving inflammation. Cell 2010, 140:871-882.
10. Aller M.A., Arias J.L., Sanchez-Patan F., Arias J. The inflammatory response: an efficient way of life. Med Sci Monit 2006, 12:RA225-RA234.
11. Aller M.A., Arias J.I., Arias J. Pathological axes of wound repair: gastrulation revisited. Theor Biol Med Model 2010, 7:37.
12. Selman M., Pardo A., Kaminski N. Idiopathic pulmonary fibrosis: aberrant recapitulation of developmental programs?. Plos Med 2008, 5:e62.
13. Aller M.A., Arias J.L., Arias J.I., Sanchez-Patan F., Arias J. The inflammatory response recapitulates phylogeny through trophic mechanisms to the injured tissue. Med Hypotheses 2007, 68:202-209.
14. Aller M.A., Arias J.I., Alonso-Poza A., Arias J. A review of metabolic staging in severely injured patients. Scand J Trauma Resusc Emerg Med 2010, 17:18-27.
15. Cone J.B. Inflammation. Am J Surg 2001, 182:558-562.
16. Aller M.A., Arias J.L., Arias J. Post-traumatic inflammatory response: perhaps a sucesión of phases with a nutricional purpose. Med Hypotheses 2004, 63:42-46.
17. Arias J.I., Aller M.A., Arias J. Surgical inflammation: a pathophysiological rainbow. J Transl Med 2009, 7:19.
18. Arias J.I., Aller M.A., Arias J. The use of inflammation by tumor cells. Cancer 2005, 104:223-228.
19. Arias J.I., Aller M.A., Arias J. Cancer cell: using inflammation to invade the host. Mol Cancer 2007, 6:29.
20. Raymond J., Segre D. The effect of oxygen on biochemical networks and the evolution of complex life. Science 2006, 311:1764-1767.
21. Acquisti C., Klefe J., Collins S. Oxygen content of transmembrane proteins over macroevolutionary time scales. Nature 2007, 445:47-52.
22. Sorokin L. The impact of the extracellular matrix on inflammation. Nat Rev Immunol 2010, 10:712-723.
23. Rhodes J.M., Simons M. The extracellular matrix and blood vessels formation: not just a scaffold. J Cell Mol Med 2007, 11:176-205.
24. Dhar A., Ray A. The CCN family proteins in carcinogenesis. Exp Oncol 2010, 32:2-9.
25. Hynes R.O., Zhao Q. The evolution of cell adhesion. J Cell Biol 2000, 150:F89-F96.
26. Telfer W.H. Egg formation in lepidoptera. J Insect Sci 2009, 9:1-21.
27. Baltz J.M., Tartia A.P. Cell volume regulation in oocytes and early embryos: connecting physiology to successful culture media. Hum Reprod Update 2010, 16:166-176.
28. Lubzens E., Young G., Bobe J., Cerda J. Oogenesis in teleosts: how fish eggs are formed. Gen Comp Endrocrinol 2010, 165:367-389.
29. Skoblina M.N. Hydration of oocytes in bony-fishes. Ontogenez 2010, 41:5-18.
30. Jiang D., Liang J., Noble P.W. Hyaluronan in tissue injury and repair. Ann Rev Cell Dev Biol 2007, 23:435-461.
31. Chen B., Fu B. A model for charged molecule transport in the interstitial space. Med Biol Sci 2005, 1:55-58. Conf Proc IEEE Eng.
32. Arukwe A., Goksyr A. Eggshell and egg yolk proteins in fish: hepatic proteins for the next generation: oogenetic, population, and evolutionary implications of endocrine disruption. Comp Hepatol 2003, 2:4.
33. Muta T., Iwanaga S. The role of hemolymph coagulation in innate immunity. Curr Opin Immunol 1996, 8:41-47.
34. Dushay M.S. Insect hemolymph clotting. Cell Mol Life Sci 2009, 66:2643-2650.
35. Jin S.-W., Patterson C. The opening act. Vasculogenesis and the origins of circulation. Arterioscler Thromb Vasc Biol 2009, 29:623-629.
36. Wasserthal L.T. Drosophila flies combine periodic heartbeat reversal with circulation in the anterior body mediated by a newly discovered anterior pair of ostial valves and " venous" channels. J Exp Biol 2007, 210:3707-3719.
37. Gabay C., Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999, 340:448-454.
38. Tufail M., Takeda M. Molecular characteristics of insect vitellogenins. J Insect Physiol 2008, 54:1447-1458.
39. Münch D., Amdam G.V. The curious case of aging plasticity in honey bees. FEBS Lett 2010, 584:2496-2503.
40. Davis R.A. Evolution of processes and regulators of lipoprotein synthesis: from birds to mammals. J Nutr 1997, 127:7955-8005.
41. Sniderman A., Couture P., De Graaf J. Diagnosis and treatment of apolipoprotein B dyslipoproteinemias. Nat Rev Endocrinol 2010, 6:335-346.
42. Natarajan P., Ray K.K., Cannon C.P. High-density lipoprotein and coronary heart disease. J Am Coll Cardiol 2010, 55:1283-1289.
43. Targher G., Day C.P., Bonora E. Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease. N Engl J Med 2010, 363:1341-1350.
44. Tarantino G., Savastano S., Colao A. Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance. World J Gastroenterol 2010, 16:4773-4783.
45. Cray C., Zaias J., Altman N.H. Acute phase response in animals: a review. Comp Med 2009, 59:517-526.
46. Kopf M., Bachmann M.F., Marsland B.J. Averting inflammation by targeting the cytokine environment. Nat Rev Drug Discov 2010, 9:703-718.
47. Jahangiri A. High-density lipoprotein and the acute phase response. Curr Opin Endrocrinol Diabetes Obes 2010, 17:156-160.
48. Czaja M.J. JNK regulation of hepatic manifestation of the metabolic syndrome. Trends Endocrinol Metab 2010, 21:707-713.
49. Marsland A.L., McCaffery J.M., Muldoon M.F., Manuck S.B. Systemic inflammation and the metabolic syndrome among middle-aged community volunteers. Metabolism 2010, 59:1801-1808.
50. Solinas G., Karin M. JNK1 and IKKβ: molecular links between obesity and metabolic dysfunction. FASEB J 2010, 24:2596-2609.
51. Wager-Smith K., Markou A. Depression: a repair response to stress-induced neuronal microdamage that can grade into a chronic neuroinflammatory condition?. Neurosci Biobehav Rev 2011, 35:742-764.
52. Sparks J.D., Cianci J., Jokinen J., Chen L.S., Sparks C.E. Interleukin-6 mediates hepatic hypersecretion of apolipodrotein B. Am J Physiol Gastrointest Liver Physiol 2010, 299:G980-G989.
53. Van der Westhuyzen D.R., De Beer F.C., Webb N.R. HDL cholesterol transport during inflammation. Curr Opin Lipidol 2007, 18:147-151.
54. Gilliver S.C. Sex steroids as inflammatory regulators. J Steroid Biochem Mol Biol 2010, 120:105-115.
55. Whaley-Connell A., Johnson M.S., Sowers J.R. Aldosterone: role in the cardiometabolic syndrome and resistant hypertension. Prog Cardiovasc Dis 2010, 52:401-409.
56. Sturmey R.G., Reis A., Leese H.J., McEvory T.G. Role of fatty acids in energy provision during oocyte maturation and early embryo development. Reprod Domest Anim 2009, 44:50-58.
57. Dumollard R., Carroll J., Duchen M.R., Campbell K., Swann K. Mitochondrial function and redox state in mammalian embryos. Semin Cell Dev Biol 2009, 20:346-353.
58. Vander Heiden M.G., Cantley L.C., Thompsson C.B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 2009, 324:1029-1033.
59. Hummasti S., Hotamislïgil G.S. Endoplasmic reticulum stress and inflammation in obesity and diabetes. Circ Res 2010, 107:579-591.
60. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 2006, 444:860-867.
61. Bayne C.J., Gerwick L. The acute phase response and innate immunity of fish. Dev Comp Immunol 2001, 25:725-743.
62. Bottazzi B., Garlanda C., Salvatori G., Jeannin P., Manfredi A., Mantovani A. Pentraxins as a key component of innate immunity. Curr Opin Immunol 2010, 18:10-15.
63. Martinez de la Torre Y., Fabbri M., Jaillon S., et al. Evolution of the pentraxin family: the new entry PTX4. J Immunol 2010, 184:5055-5064.
64. Litvack M.L., Palaniyar N. Soluble innate immune pattern-recognition proteins for clearing dying cells and cellular components: implications on exacerbating or resolving inflammation. Innate Immun 2010, 16:191-200.
65. Castaño A.P., Lin S.-L., Surowy T., et al. Serum amyloid P inhibits fibrosis through Fcrγ-dependent monocyte-macrophage regulation in vivo. Sci Transl Med 2009, 1:1-11.
66. Inforzato A., Rivieccio V., Morreale A.P., et al. Structural characterization of PTX3 disulfide bond network and its multimeric status in cumulus matrix organization. J Biol Chem 2008, 283:10147-10161.
67. Cillo F., Brevini T.A.L., Antonini S., Paffoni A., Ragni G., Gandolfi F. Association between human oocyte developmental competent and expression levels of some cumulus genes. Reproduction 2007, 134:645-650.
68. Pisani L.F., Antonini S., Pocar P., et al. Effects of pre-mating nutrition on mRNA levels of developmentally relevant genes in sheep/oocytes and granulosa cells. Reproduction 2008, 136:303-312.
69. Scarchilli L., Camaioni A., Bottazzi B., et al. PTX3 interacts with Inter-α-trypsin inhibitor. Implications for hyaluronan organization and cumulus oophorous expansion. J Biol Chem 2007, 282:30161-30170.
70. Deban L., Jaillon S., Garlanda C., Bottazzi B., Mantovani A. Pentraxis in innate immunity: lessons from PTX3. Cell Tissue Res 2011, 343:237-249.
71. Rusnati M., Camozzi M., Moroni E., et al. Selective recognition of fibroblast growth factor-2 by the long pentraxin PTX3 inhibits angiogenesis. Blood 2004, 104:92-99.
72. Leali D., Alessi P., Coltrini D., Rusnati M., Zetta L., Presta M. Fibroblast growth factor-2 antagonist and antiangiogenic activity of long-pentraxin 3-derived synthetic peptides. Curr Pharm Des 2009, 15:3577-3589.
73. Muszbek L., Bereczky Z., Bagoly Z., Shemirani A.H., Katona E. Factor XIII and atherothrombotic diseases. Semin Thromb Hemost 2010, 36:18-33.
74. Crivellato E., Ribatti D. The mast cell: an evolutionary perspective. Biol Rev 2010, 85:347-360.
75. Galli S.J., Kalesnikoff J., Grimbaldeston M.A., Piliponsky A.M., Williams C.M.M., Tsai M. Mast cells as " tunable" effector and immunoregulatory cells: recent advances. Ann Rev Immunol 2005, 23:749-786.
76. Bachelet I., Levi-Schaffer F. Mast cells as effector cells, a costimulating question. Trends Immunol 2007, 28:360-365.
77. Hu Z.-Q., Zhao W.-H., Shimamura T. Regulation of mast cell development by inflammatory factors. Curr Top Med Chem 2007, 14:3044-3050.
78. Molmenti E.P., Ziambaras T., Perlmutter D.H. Evidence for an acute phase response in human intestinal epithelial cells. J Biol Chem 1993, 288:14116-14124.
79. Wang Q., Wang J.J., Boyce S., Fischer J., Hasseigren P.O. Edotoxemia and IL-1β stimulate mucosal IL-6 production in different parts of the gastrointestinal tract. J Surg Res 1998, 76:27-31.
80. Pritts T., Hungness E., Wang Q., Robb B., Hershko D., Hasselgren P.-O. Mucosal and enterocyte IL-6 production during sepsis and endotoxemia-role of transcription factors and regulation by the stress response. Am J Surg 2002, 183:372-383.
81. Tilg H. The role of cytokines in non-alcoholic fatty liver disease. Dig Dis 2010, 28:179-185.
82. Bui Q.T., Prempeh M., Wilensk R.L. Atherosclerotic plaque development. Int J Biochem Cel Biol 2009, 41:2109-2113.
83. Yeong P., Ning Y., Xu Y., Li X., Yin L. Tryptase promotes human monocyte-derived macrophage from cell formation by suppressing LXRα activation. Biochem Biophys Acta 2010, 1801:567-576.
84. Poglio S., De Toni-Costes F., Arnaud E., et al. Adipose tissue as a dedicated reservoir of functional mast cell progenitors. Stem Cell 2010, 28:2065-2072.
85. Fukunaga M., Nunomura S., Nishida S., et al. Mast cell death induced by 24(S), 25-epoxycholesterol. Exp Cell Res 2010, 316:3272-3281.
86. Gutierrez E., Wiggins D., Fielding B., Gould A.P. Specialized hepatocyte-like cells regulate Drosophila lipid metabolism. Nature 2007, 445:275-280.
87. Gould A.P., Elstob P.R., Brodu V. Insect oenocytes: a model system for studying cell-fate specification by Hox genes. J Anat 2001, 199:25-33.
88. Schlegel A., Stainier D.Y.R. Lessons from " lower" organisms: what worms, flies and zebra fish can teach us about human energy metabolism. Plos Genet 2007, 3:e199.
89. Pospisilik J.A., Schramek D., Schnidar H., et al. Drosophila genome-wide obesity screen reveals hedgehog as a determinant of brown versus white adipose cell fate. Cell 2010, 140:148-160.
90. Paris M., Laudet V. The history of a developmental stage: metamorphosis in chordates. Genesis 2008, 46:657-672.
91. Aller M.A., Arias J.L., Nava M.P., Arias J. Evolutive trophic phases of the systemic acute inflammatory response, oxygen use mechanisms and metamorphosis. Psicothema 2004, 16:369-372.
92. Agarwal A.K., Auchus R.J. Minireview: cellular redox state regulates hydroxysteroid dehydrogenase activity and intracellular hormone potency. Endocrinology 2005, 146:2531-2538.
93. Ghosh S., Hayden M.S. New regulators of NF-κB in inflammation. Nat Rev 2008, 8:837-849.
94. Serhan C.N., Brain S.D., Buckley C.D., et al. Resolution of inflammation: state of the art, definitions and terms. FASEB J 2007, 21:325-332.
95. Lawrence T., Gilroy D.W. Chronic inflammation: a failure of resolution?. Int J Exp Path 2007, 88:85-94.
96. Buchanan E.P., Longaker M.T., Lorenz H.P. Fetal skin wound healing. Adv Clin Chem 2009, 48:137-161.
97. Mikawa T., Poh A.M., Kelly K.A., Ishii Y., Reese D.E. Induction and patterning of the primitive streak, and organizing center of gastrulation in the amniote. Dev Dyn 2004, 229:422-432.
98. Elinson R.P., Beckham Y. Development in frogs with large eggs and the origin of amniotes. Zoology 2002, 105:105-117.
99. Bellini C., Boccardo F., Bonioli E., Campisi C. Lymphodynamics in the fetos and newborn. Lymphology 2006, 39:110-117.
100. Chang Y.J., Hwang S.M., Tseng C.P., et al. Isolation of mesenchymal stem cells with neurogenic potentials from the mesoderm of the amniotic membrane. Cells Tissues Organs 2010, 192:93-105.
101. De Miguel M.P., Arnalich-Montiel F., Lopez-Iglesias P., Blázquez-Martinez A., Nistal M. Epiblast-derived stem cells in embryonic and adult tissue. Int J Dev Biol 2009, 53:1529-1540.
102. Acloque H., Adams M.S., Fishwick K., Bronner-Fraser M., Nieto M.A. Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease. J Clin Invest 2009, 119:1438-1449.
103. Feng B., Chen L. Review of mesenchymal stem cells and tumors: executioner or conspirator?. Cancer Biother Radiopharm 2009, 24:717-721.
104. Kalluri R., Neilson E.G. Epithelial-mesenchymal transition and its implications for fibrosis. J Clin Invest 2003, 112:1776-1782.
105. Kragl M., Knapp D., Nacu E., et al. Cells keep a memory of their tissue origin during axo to limb regeneration. Nature 2009, 460:60-65.
106. Zuba-Surma E.K., Kucia M., Ratajczak J., Ratajczak M.Z. " Small stem cells" in adult tissues: very small embryonic-like stem cells (VSELs) stand up. Cytometry 2010, 75:4-13.
107. Kuroda Y., Kitada M., Wakao S., et al. Unique multipotent cells in adult human mesenchymal cell populations. PNAS 2010, 107:8639-8643.
108. Roszko I., Sawada A., Solnica-Krezel L. Regulation of convergent and extension movements during vertebrate gastrulation by the Wnt/PCP pathway. Semin Cell Develop 2009, 20:986-997.
109. Torre C., Perret C., Colnot S. Transcription dynamics in a physiological process: β-catenin signaling directs liver metabolic zonation. Int J Biochem Cell Biol 2011, 43:271-278.
110. Sugimura R., Li L. Non canonical Wnt signaling in vertebrate development, stem cells and diseases. Birth Defects Res C Embryo Today 2010, 90:243-256.
111. Sethi J.K., Vidal-Puig A. Wnt signalling and the control of cellular metabolism. Biochem J 2010, 427:1-17.
112. Li L., Clevers H. Coexistance of quiescent and active adult stem cells in mammals. Science 2010, 327:542-545.
113. Budnik V., Salinas P.C. Wnt signaling during synaptic development and plasticity. Curr Opin Neurobiol 2011, 21:151-159.
114. Krenning G., Zeisberg E.M., Kalluri R. The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 2010, 225:631-637.
115. Latimer A., Jessen J.R. Extracellular matrix assembly and organization during zebrafish gastrulation. Matrix Biol 2010, 29:89-96.
116. Wolfson M., Budovsky A., Tacutu R., Fraifeld V. The signaling hubs at the cross road of longevity and age-related disease networks. Int J Biochem Cell Biol 2009, 41:516-520.
117. Muller G.B. Evo-devo: extending the evolutionary synthesis. Nat Rev Genet 2007, 8:943-949.
118. Choudhuri S., Cui Y., Klaassen C.D. Molecular targets of epigenetic regulation and effectors of environmental influences. Toxicol Appl Pharmacol 2010, 245:378-393.
119. Duvnjak L., Duvnjak M. The metabolic syndrome - an ongoing story. J Physiol Pharmacol 2009, 60:19-24.
120. Grundy S.M., Adams-Huet B., Vega G.L. Variable contributions of fat content and distribution to metabolic syndrome risk factors. Metab Syndr Relat Disord 2008, 6:281-288.
121. Halpern A., Mancini M.C., Magalhães M.E., et al. Metabolic syndrome, dyslipidemia, hypertension and type 2 diabetes in youth: from diagnosis to treatment. Diabetol Metab Syndr 2010, 2:55.
122. Blüher M. Fat tissue and long life. Obesity Facts 2008, 1:176-182.
123. Nathan C. Epidemic inflammation: pondering obesity. Mol Med 2008, 14:485-492.
124. Kiecolt-Glaser J.K., Gouin J.P., Hantsoo L. Close relationships, inflammation and death. Neurosci Biobehav Rev 2010, 35:33-38.
125. Hamer M., Malan L. Psychophysiological risk markers of cardiovascular disease. Neurosci Biobehav Rev 2010, 35:76-83.
126. Hänsel A., Hong S., Camara R.J.A., Von Kämel R. Inflammation as a psychophysiological biomarker in chronic psychosocial stress. Neurosci Biobehav Rev 2010, 35:115-121.
127. Hansen C.H., Gilman A.P., Odland J.O. Is thermogenesis a significant causal factor in preventing the " globesity" epidemic?. Med Hypotheses 2010, 75:250-256.